|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
118,790,000 |
Market
Cap: |
42.71(M) |
Last
Volume: |
19,275,386 |
Avg
Vol: |
9,179,628 |
52
Week Range: |
$0.3595 - $0.3595 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Novavax is a biotechnology company that promotes improved global health through the discovery, development and commercialization of vaccines to prevent serious infectious diseases. Co.'s vaccine candidates, including both its coronavirus vaccine candidate, NVX-CoV2373, and its primary influenza vaccine candidate, NanoFlu, are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 and NanoFlu include the use of Co.'s proprietary Matrix-M adjuvant.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
6,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$43,042 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
3 |
Total Shares Sold |
0 |
0 |
0 |
12,500 |
Total Sell Value |
$0 |
$0 |
$0 |
$919,765 |
Total People Sold |
0 |
0 |
0 |
1 |
Total Sell Transactions |
0 |
0 |
0 |
1 |
End Date |
2023-12-28 |
2023-09-26 |
2023-03-28 |
2022-03-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Singhvi Rahul |
President, CEO |
|
2009-07-01 |
4 |
OE |
$0.74 |
$111,000 |
D/D |
150,000 |
371,438 |
|
- |
|
Hage Raymond Joseph |
Sr. VP. Commercial Operations |
|
2009-07-01 |
4 |
S |
$3.07 |
$19,273 |
D/D |
(6,261) |
5,251 |
|
- |
|
Johnston Thomas Scott |
Vice President, Strategy |
|
2009-07-01 |
4 |
S |
$3.05 |
$45,878 |
D/D |
(15,000) |
11,000 |
|
- |
|
Satellite Overseas (holdings) Ltd |
10% Owner |
|
2009-03-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
12,500,000 |
|
- |
|
Modi Rajiv I. |
Director |
|
2009-03-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
12,500,000 |
|
- |
|
Hage Raymond Joseph |
SVP, Commercial Operations |
|
2008-09-19 |
4 |
S |
$3.11 |
$62,204 |
D/D |
(20,000) |
73,534 |
|
- |
|
Hage Raymond Joseph |
SVP, Commercial Operations |
|
2008-09-18 |
4 |
S |
$2.93 |
$29,398 |
D/D |
(10,000) |
93,534 |
|
- |
|
Robinson Jim |
VP, Tech. & Quality Operations |
|
2008-07-31 |
4 |
B |
$0.00 |
$0 |
D/D |
17,590 |
77,590 |
2.66 |
- |
|
Mcmanus Michael A Jr |
Director |
|
2008-07-31 |
4 |
B |
$0.00 |
$0 |
D/D |
17,590 |
77,590 |
2.31 |
- |
|
Monath Thomas P |
Director |
|
2008-07-31 |
4 |
B |
$0.00 |
$0 |
I/I |
358,803 |
3,225,366 |
2.02 |
- |
|
Singhvi Rahul |
President, CEO |
|
2008-07-31 |
4 |
B |
$0.00 |
$0 |
D/D |
10,554 |
221,438 |
2.73 |
- |
|
Evans Gray C |
Director |
|
2008-07-31 |
4 |
B |
$0.00 |
$0 |
D/D |
67,756 |
911,056 |
2.31 |
- |
|
Heaton Penny |
Chief Medical Officer |
|
2008-07-31 |
4 |
B |
$0.00 |
$0 |
D/D |
1,759 |
28,159 |
2.66 |
- |
|
Johnston Thomas Scott |
Vice President, Strategy |
|
2008-07-31 |
4 |
B |
$0.00 |
$0 |
D/D |
1,000 |
26,000 |
2.66 |
- |
|
Stigliano Len F |
VP, CFO, Treasurer |
|
2008-07-31 |
4 |
B |
$0.00 |
$0 |
D/D |
10,554 |
20,554 |
2.66 |
- |
|
Lambert John A |
Director |
|
2008-07-31 |
4 |
B |
$0.00 |
$0 |
D/D |
14,746 |
114,746 |
2.31 |
- |
|
Tananbaum James B |
Director |
|
2008-07-31 |
4 |
B |
$0.00 |
$0 |
I/I |
35,181 |
3,151,818 |
2.02 |
- |
|
Johnston Thomas Scott |
Vice President, StrategyOffice |
|
2008-06-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,000 |
|
- |
|
Heaton Penny |
Chief Medical Officer |
|
2008-01-30 |
4 |
B |
$3.05 |
$6,100 |
D/D |
2,000 |
27,000 |
2.74 |
- |
|
Robinson Jim |
VP,Technical & Quality Oper. |
|
2008-01-09 |
4 |
B |
$3.07 |
$15,325 |
D/D |
5,000 |
60,000 |
2.74 |
- |
|
Singhvi Rahul |
President, CEO |
|
2007-08-28 |
4 |
B |
$3.04 |
$3,342 |
D/D |
1,100 |
210,884 |
2.73 |
- |
|
Hage Raymond Joseph |
SVP, Commercial Operations |
|
2007-08-27 |
4 |
S |
$3.15 |
$33,230 |
D/D |
(10,500) |
103,534 |
|
- |
|
Stigliano Len F |
VP, CFO, Treasurer |
|
2007-08-24 |
4 |
B |
$3.14 |
$31,400 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
Evans Gray C |
Director |
|
2007-08-23 |
4 |
B |
$3.02 |
$30,200 |
D/D |
10,000 |
843,300 |
2.39 |
- |
|
Evans Gray C |
Director |
|
2007-08-22 |
4 |
B |
$3.10 |
$61,980 |
D/D |
20,000 |
833,300 |
2.39 |
- |
|
155 Records found
|
|
Page 4 of 7 |
|
|